**Acknowledgements**

AL is grateful for financial assistance from the National Research Foundation (NRF) of South Africa (Grant Number 94942). Opinions expressed and conclusions arrived at are those of the authors and are not to be attributed to the NRF.

[9] Cleveland J, Montville TJ, Nes IF, Chikindas ML. Bacteriocins: Safe, natural antimicrobials for food preservation. International Journal of Food Microbiology. 2001;**71**:1-20

The Cytotoxic, Antimicrobial and Anticancer Properties of the Antimicrobial Peptide Nisin Z…

http://dx.doi.org/10.5772/intechopen.71927

37

[10] Kaur S, Kaur S. Bacteriocins as potential anticancer agents. Frontiers in Pharmacology.

[11] Luqmani YA. Mechanisms of drug resistance in cancer chemotherapy. Medical Principles and Practice: International Journal of the Kuwait University, Health Science

[12] Soengas MS, Lowe SW. Apoptosis and melanoma chemoresistance. Oncogene. 2003;**22**:

[13] Wellbrock C. MAPK pathway inhibition in melanoma: Resistance three ways. Biochemi-

[14] Sylvester PW, Wali VB, Bachawal SV, Shirode AB, Ayoub NM, Akl MR. Tocotrienol combination therapy results in synergistic anticancer response. Frontiers in Bioscience.

[15] Wei XQ, Ma HQ, Liu AH, Zhang YZ. Synergistic anticancer activity of 5-aminolevulinic acid photodynamic therapy in combination with low-dose cisplatin on Hela cells. Asian

[16] Preet S, Bharati S, Panjeta A, Tewari R, Rishi P. Effect of nisin and doxorubicin on DMBAinduced skin carcinogenesis—A possible adjunct therapy. Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine. 2015;**36**:8301-

[17] O'Neill J. The review on antimicrobial resistancs. Tackling Drug-Resistant Infections Globally: Final Report and Recommendations. [Online]. 2016. Available: https://amrreview.org/sites/default/files/160518\_Final%20paper\_with%20cover.pdf [Accessed: 16

[18] Hancock RE, Sahl HG. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nature Biotechnology. 2006;**24**:1551-1557. DOI: 10.1038/nbt1267

[19] Rogers LA, Whittier EO. Limiting factors in the lactic fermentation. Journal of Bacterio-

[20] Mulders JW, Boerrigter IJ, Rollema HS, Siezen RJ, de Vos WM. Identification and characterization of the lantibiotic nisin Z, a natural nisin variant. European Journal of

[21] De Vos WM, Mulders JW, Siezen RJ, Hugenholtz J, Kuipers OP. Properties of nisin Z and distribution of its gene, nisZ, in *Lactococcus lactis*. Applied and Environmental

[22] De VWM, Kuipers OP, Siezen RJ. Lantibiotics similar to nisin a, lactic acid bacteria which produce such lantibiotics, method for constructing such lactic acid bacteria and method

cal Society Transactions. 2014;**42**:727-732. DOI: 10.1042/BST20140020

Pacific Journal of Cancer Prevention: APJCP. 2013;**14**:3023-3028

2015;**6**:272. DOI: 10.3389/fphar.2015.00272

3138-3151. DOI: 10.1038/sj.onc.1206454

8308. DOI: 10.1007/s13277-015-3571-3

2011;**16**:3183-3195

January 2017]

logy. 1928;**16**:211-229

Biochemistry. 1991;**201**:581-584

Microbiology. 1993;**59**:213-218

Centre. 2005;**14**(Suppl 1):35-48. DOI: 10.1159/000086183
